National Foundation For Cancer Research logo

National Foundation For Cancer Research

Public charity · Grantmaker Rockville, MD EIN: 04-2531031 Website

The National Foundation for Cancer Research (NFCR) is a public charity based in Rockville, Maryland, that funds cancer research and public education. Founded in 1973, it describes its approach as supporting high-risk, high-impact research, including work intended to move discoveries toward improved cancer detection, prevention, and treatment.

National Foundation For Cancer Research at a glance

In short: National Foundation For Cancer Research gave $3.3M across 20 grants in 2024 (avg $167K), top state Maryland. 20% of 2024 grantees were new. Source: 2024 IRS Form 990.

Annual giving (2024)
$3,331,348
+6.0% vs 2023
Grants made (2024)
20
+0.0% vs 2023
Average grant
$166,567
+6.0% vs 2023
Median grant
$140,000
Total assets
$12,279,522
+16.6% vs 2023
New grantees (estimate)
20% first-time grantees (4 of 20, 2024; small sample)
Primary geography
Maryland (29% of itemized 2024 grant dollars)
Latest 990 filing
Form 990, 2024 View filing

Data from IRS Form 990, 2024; updated September 2026. New grantees are estimated by matching recipient names across years (methodology).

How to apply to National Foundation For Cancer Research

Contact

Mailing address: 5515 Security Lane Suite 1105, Rockville, MD 20852
Phone: (301) 654-1250
Website: https://nfcr.org

Application details from Grantable's research on the foundation's public materials; confirm on its website before applying.

Who National Foundation For Cancer Research funds

How this funder distributes its grants

Top Recipients

Top 10 recipients in 2024

Aim Hi Accelerator Fund: $870KAim Hi Accelerator Fund$870KMassachusetts General Hospital: $352KMassachusetts General Hospital$352KColumbia University: $250KColumbia University$250KYale University: $230KYale University$230KUniversity of Pennsylvania: $211KUniversity of Pennsylvania$211KThe Scripps Research Institute: $200KThe Scripps Research Institute$200KDana-Farber Cancer Institute: $152KDana-Farber Cancer Institute$152KNew York University Grossman School Med: $148KNew York University GrossmanSchool Med$148KMD Anderson Cancer Center: $140KMD Anderson Cancer Center$140KHenry Ford Health System: $140KHenry Ford Health System$140K

The largest 2024 recipient was Aim Hi Accelerator Fund ($870K). Together the top 10 received $2.7M.

Grant Size Distribution

75 grants across all recorded years

17<$50K24$50–100K22$100–250K5$250–500K4$500K–1M3$1–5M$5M+

The most common grant size was in the $50–100K range: 24 grants of 75 (32%).

Geographic Focus

Where this funder awards grants

NFCR is based in Rockville, Maryland. Its 2024 grant dollars went to recipients in multiple states; the largest shares were in Maryland (29%), New York (17%), Massachusetts (15%), California (8%), and Connecticut (7%). The Recoverable Translational Research Grants program description gives an international geographic scope, and AIM-HI’s description says its scope is the United States and worldwide.

Grant Distribution by State

17states

Share of 2024 grant dollars across all 20 itemized grants.

Cities

New YorkBostonLa JollaPhiladelphiaRockvilleKansas CityBaltimoreClevelandNew HavenNormanPortlandSeattleDetroitHoustonLexingtonRichmondWinston-SalemBronxDallasLewes

Is National Foundation For Cancer Research open to new grantees?

20%

first-time grantees, 2024

In 2024, 4 of 20 grantees (20%) were first-time recipients. With only 20 grantees, that is a small sample: one grantee more or less moves the share by about 5 points. First grants averaged $134K; repeat grants $175K. How we count

Medians: $140K first-time, $130K repeat.

  • 75% of 2024 grantees were also funded in 2023. Method
  • Giving held roughly steady from 2021 to 2024 (−17%). Method

Estimate from itemized grant lists in IRS Form 990 filings (2020–2024). Recipient names are matched across years, so a renamed or misspelled grantee can look new; grants to individuals are left out. Methodology.

Giving History

Giving Over Time

Total grant dollars and number of grants per year

$0$1M$2M$3M$4M11 grants2020 7 grants2021 17 grants2022 20 grants2023 20 grants2024

From 2020 to 2024, annual grant giving ranged from $2.0M (2022) to $4.0M (2021). In 2024 it made 20 grants totaling $3.3M.

Grants by year

Grant recipients and amounts by year

RecipientPurposeAmount
Aim Hi Accelerator Fund Rockville, MDcollaboration$870,000
Massachusetts General Hospital Boston, MAResearch Contracts$352,092
Columbia University New York, NYResearch Contracts$250,000
Yale University New Haven, CTResearch Contracts$230,000
University of Pennsylvania Philadelphia, PAResearch Contracts$211,120
The Scripps Research Institute La Jolla, CAResearch Contracts$200,000
Dana-Farber Cancer Institute Boston, MAResearch Contracts$152,340
New York University Grossman School Med New York, NYResearch Contracts$147,983
MD Anderson Cancer Center Houston, TXResearch Contracts$140,000
Henry Ford Health System Detroit, MIResearch Contracts$140,000
Your AI grants department

Ready to take the next step with National Foundation For Cancer Research?

Fully replaces Grant database subscriptions Instrumentl · Foundation Directory · GrantStation & similar

Financial History

Multi-year comparison from IRS filings

Figures from IRS filings, by filing year
Filing yearTotal AssetsRevenueExpensesGrants paidGrantsNet Investment Income
2024$12,279,522$11,095,696$9,799,090$3,331,34820$691,486
2023$10,533,674$9,162,442$9,790,531$3,141,80420$370,595
2022$10,719,078$8,408,059$8,484,908$2,030,46117$138,215
2021$12,143,234$10,081,253$10,194,507$3,989,8047$464,445
2020$12,283,856$11,465,290$10,830,001$3,699,65811$271,161

Research compiled by Grantable AI from public sources. Last updated September 2026.

Mission & Focus Areas

NFCR’s stated mission is to support cancer research and public education relating to prevention, earlier diagnosis, better treatments, and ultimately a cure for cancer. Its listed research focus areas include cancer formation; diagnosis and molecular imaging; genomics and biomarkers; early detection and prevention; immunotherapy; metastasis; the tumor microenvironment; clinical research and trial platforms; transformative therapies; computational biology; and circulating tumor cells.

NFCR’s 2024 filing says that in 2023–2024 it funded 37 scientists working across more than 15 cancer types, and that supported discoveries advanced seven therapies into clinical trial phases: five in Phase 1 and two in Phase 2. The filing also describes public education activities, including cancer-prevention materials and community outreach.

The 2024 grants include research contracts to universities, hospitals, and research organizations. For example, Scripps Research Institute describes its own mission as conducting basic biomedical research and translating discoveries into useful products. Henry Ford Health describes its mission as improving people’s lives through health care and healing; Johns Hopkins University emphasizes education, original research, and bringing discovery’s benefits to the world.

Grantmaking

In 2024, NFCR reported 20 grants totaling $3,331,348. Grant amounts ranged from $5,912 to $870,000, with a median of $140,000. The largest award was $870,000 to AIM HI Accelerator Fund in Rockville, Maryland, for collaboration. Other large awards included $352,092 to Massachusetts General Hospital, $250,000 to Columbia University, $230,000 to Yale University, and $211,120 to the University of Pennsylvania, each listed for research contracts.

NFCR’s listed programs include the Salisbury Award for Entrepreneurial Translational Research, which recognizes early-stage cancer therapeutic, diagnostic, or vaccine projects and offers cash prizes of $3,000 for the winner and $1,500 for the runner-up. The program description says eligible investigators may be faculty or non-faculty at world-class institutions; evaluation considers novelty, feasibility, impact, patentability, and a clear clinical-trial pathway. It also describes a possible route to compete for multiyear Recoverable Translational Research Grants.

The Recoverable Translational Research Grants are described as multiyear support for early-stage projects that validate laboratory findings and move viable therapeutic, diagnostic, or preventive candidates toward clinical trials and patient use. The recoverable model expects repayment upon commercialization success. NFCR also describes the AIM-HI Accelerator Fund as using venture philanthropy and impact investments to help advance early-stage cancer innovations toward clinical application. Its 2024 filing lists an $870,000 grant to AIM HI Accelerator Fund.

Leadership & Key People

Leadership team and compensation from IRS filings

Officers and directors listed on NFCR’s 2024 filing include Sujuan Ba, President/CEO; Kwok Leung, CFO/Secretary; Brian Wachtel, Chief Development Officer/Executive Director; Zeting Wang, Senior Director of Direct Response; Alfred Slanetz, Chair of the Board; and Brian Leyland-Jones, Treasurer. The filing also lists Judith P. Barnhard, Karen Burke, Franklin Salisbury Jr. (effective January 31, 2024), and Silas Deane (effective May 24, 2024) as directors.

National Foundation For Cancer Research is led by Sujuan Ba, President & CEO on every filing since 2020; 4 of 12 officers listed in 2024 are compensated.

Officers on the 2024 filing

  • Sujuan Ba

    President & CEO

    On filings since 2020

    40 hrs/week

    $343K (2020) → $462K (2024)

  • Brian Wachtel

    Chief Development Officer & Executive Director

    Executive Director → Chief Development Officer & Executive Director, 2024

    On filings since 2020

    40 hrs/week

    $126K (2020) → $166K (2024)

  • Alfred Slanetz

    Chair of the Board

    Director → Chair of the Board, 2022

    On filings since 2020

    5 hrs/week

    No compensation reported

  • Franklin C. Salisbury Jr.

    Director

    CEO Emeritus → Director, 2024

    On filings since 2020

    1 hr/week

    $231K (2020) → $0 (2024)

  • Zeting Wang

    Senior Director of Direct Response

    On filings since 2022

    40 hrs/week

    $130K (2022) → $124K (2024)

  • Judith P. Barnhard

    Director

    Chair → Director, 2022

    On filings since 2020

    1.5 hrs/week

    No compensation reported

  • Padmakumar Kaimal

    Director

    On filings since 2020

    1 hr/week

    No compensation reported

  • Karen Burke

    Director

    On filings since 2022

    1 hr/week

    No compensation reported

  • Lance Kawaguchi

    Director

    On filings since 2022

    1 hr/week

    No compensation reported

  • Silas Deane

    Director

    New on the 2024 filing

    1 hr/week

    No compensation reported

  • Kwok Leung

    CFO & Secretary

    On filings since 2020

    40 hrs/week

    $187K (2020) → $231K (2024)

  • Brian Leyland-Jones

    Treasurer

    Director → Treasurer, 2023

    On filings since 2021

    2 hrs/week

    No compensation reported

Former officers (7)
  • Former: Edward s west (2020–2023) — Director
  • Former: Wendi P. Dennard (2020–2022) — Director
  • Former: Yi Wang (2020–2022) — Chief Strtgy Officer
  • Former: Bradley Gillenwater (2020–2021) — Senior Director for Corp. Outreach
  • Former: Gus Kodersha (2020) — Director
  • Former: Joseph F. Franlin (2020) — Director
  • Former: William Scandone (2020) — Director

Data from IRS Form 990 filings, 2020–2024. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.

Compensation Overview

From 2024 IRS filing

Sujuan Ba — President/CEO: $462KSujuan BaPresident/CEO$462KKwok Leung — CFO/Secretary: $231KKwok LeungCFO/Secretary$231KBrian Wachtel — Chief Dev Officer/Exec. DIR: $166KBrian WachtelChief Dev Officer/Exec. DIR$166KZeting Wang — Senior DIR of Direct Response: $124KZeting WangSenior DIR of Direct Response$124K

The highest reported compensation on the 2024 filing was $462K, to Sujuan Ba (President/CEO). 4 officers or directors reported compensation on that filing.

Frequently asked questions about National Foundation For Cancer Research

How much does National Foundation For Cancer Research give each year?

National Foundation For Cancer Research gave $3.3M across 20 grants in 2024, according to its 2024 IRS Form 990. In 2023 it gave $3.1M across 20 grants.

What is National Foundation For Cancer Research's typical grant size?

National Foundation For Cancer Research's median grant in 2024 was $140,000, and its average grant was $166,567, across 20 grants on its 2024 IRS Form 990. Organizations receiving their first grant from National Foundation For Cancer Research that year got $134K on average.

Where does National Foundation For Cancer Research give grants?

National Foundation For Cancer Research's top state is Maryland, with 29% of the grant dollars itemized on its 2024 IRS Form 990. The next largest states were New York (17%) and Massachusetts (15%). The most frequent recipient cities were New York, NY (3 grants), Boston, MA (2 grants), La Jolla, CA (2 grants) and Philadelphia, PA (2 grants).

Does National Foundation For Cancer Research give general operating support?

Not in 2024: none of the 20 grants with a stated purpose on National Foundation For Cancer Research's 2024 IRS Form 990 were described as general or operating support. Recurring purposes include "Research Contracts" (19 grants).

Who are National Foundation For Cancer Research's largest grantees?

National Foundation For Cancer Research's largest 2024 grantees include Aim Hi Accelerator Fund ($870,000), Massachusetts General Hospital ($352,092) and Columbia University ($250,000), according to its 2024 IRS Form 990. Together they received 44% of its itemized 2024 grant dollars.

How large is National Foundation For Cancer Research?

National Foundation For Cancer Research reported $12.3M in total assets on its 2024 IRS Form 990. Its revenue that year was $11.1M.

What does National Foundation For Cancer Research fund?

NFCR’s stated mission is to support cancer research and public education relating to prevention, earlier diagnosis, better treatments, and ultimately a cure for cancer. See mission & focus areas ↑

How do I apply for a grant from National Foundation For Cancer Research?

National Foundation For Cancer Research has no public application process in the sources Grantable reviewed. Check nfcr.org for current guidelines, or contact the foundation directly before submitting a request.

What is National Foundation For Cancer Research's EIN?

National Foundation For Cancer Research's EIN (Employer Identification Number) is 04-2531031. IRS Form 990 filing data is available on this page for 2020–2024.

Data last updated September 2026. Sourced from IRS Form 990 filings. Research dossier generated September 2026.

Data update history

(6)

When this profile's IRS filing data changed on Grantable

  1. Updated Form 990 for fiscal year 2020 (received by the IRS July 30, 2021)
  2. Updated Form 990 for fiscal year 2021 (received by the IRS September 20, 2022)
  3. Updated Form 990 for fiscal year 2022 (received by the IRS October 24, 2023)
  4. Updated Form 990 for fiscal year 2023 (received by the IRS September 5, 2024)
  5. Updated Form 990 for fiscal year 2024 (received by the IRS November 10, 2025)
  6. IRS filings on file for fiscal years 2020–2024

Explore Open Grants

Browse active grant opportunities in National Foundation For Cancer Research's focus areas in our free grants database

Similar Funders

Funders that support many of the same organizations

Emory University

Atlanta, GA

Emory University primarily funds research and subcontract work for universities, hospitals, research organizations, and other organizations, across a range of academic and health-related fields. Its 2025 grants ranged from $5,500 to $19.1 million, with a median of about $97,000; 41% of grant dollars went to Georgia recipients. The profile does not state whether Emory accepts unsolicited requests.

Assets

$24.9B

Grants

362

Total Given

$183.7M

Yale University

New Haven, CT

Yale University funds sponsored research, education and institutional programs, student aid, and charitable or community support, with 2025 grants ranging from $3,000 to $14.3 million and a median of about $136,000. Grants went to recipients in multiple states, with the largest shares in Connecticut, California, Massachusetts, New York, and Pennsylvania. The information does not state whether Yale accepts unsolicited requests.

Education

Assets

$58.9B

Grants

364

Total Given

$168.2M

American Heart Association Inc

Dallas, TX

The American Heart Association funds basic, clinical, behavioral, translational and population research on cardiovascular, cerebrovascular and brain health, along with research training and education programs. In 2025 it awarded 833 grants totaling about $198 million; amounts ranged from $5,000 to nearly $9.93 million, with a median of $20,000. Research awards are for eligible U.S.-based nonprofit institutions, and the profile describes a formal proposal process but does not state whether unsolicited requests are accepted.

Diseases, Disorders & Medical Disciplines

Assets

$2.0B

Grants

833

Total Given

$198.2M

The Trustees of Columbia University in the City of New York

New York, NY

Columbia funds research, education and research, and capital projects, primarily through grants to universities and medical and research institutions across the United States, with the largest share going to New York recipients. Its 2025 grants had a median of about $109,000, though awards ranged from $5,350 to $15.1 million. The profile does not state whether it accepts unsolicited requests.

Assets

$26.0B

Grants

417

Total Given

$208.3M

Vanderbilt University Medical Center

Nashville, TN

Vanderbilt University Medical Center supports medical and scientific research, health and educational programs, and related institutional purposes, with grants to universities, medical centers, and research organizations. Its 2025 grants had a median of about $116,000, though awards ranged widely; recipients were based across the U.S., with the most funding going to Tennessee. The profile does not state whether it accepts unsolicited requests.

Health

Assets

$7.8B

Grants

246

Total Given

$125.1M

Cystic Fibrosis Foundation

Bethesda, MD

The Cystic Fibrosis Foundation funds cystic fibrosis research, drug development, specialized care, and related training and clinical programs. In 2024, its grants had a median of about $150,000, with awards ranging from $2,800 to nearly $12.9 million; it supports work nationwide. Applications are submitted through specific funding opportunities, but the profile does not state whether unsolicited requests are accepted.

Diseases, Disorders & Medical Disciplines

Assets

$5.0B

Grants

624

Total Given

$189.6M

More similar funders

More Funders in Maryland

Cite this profile

Grantable. (2026). National Foundation For Cancer Research funder profile. GrantGraph. Retrieved October 10, 2026, from https://grantable.co/funders/national-foundation-for-cancer-research-morg_5ec970f512ed4493884f5f0589dfa091

BibTeX
@misc{grantable_042531031_2026,
  author       = {{Grantable}},
  title        = {{National Foundation For Cancer Research funder profile}},
  howpublished = {GrantGraph},
  year         = {2026},
  url          = {https://grantable.co/funders/national-foundation-for-cancer-research-morg_5ec970f512ed4493884f5f0589dfa091},
  note         = {Accessed 2026-10-10. Data licensed CC BY 4.0}
}

The figures on this page are open data under CC BY 4.0: reuse them with credit to Grantable and a link. Download the data.

Figures come from National Foundation For Cancer Research's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.

National Foundation For Cancer Research down — hundreds of funders to go?

Want AI to do this for you?